Search - tctmd.com

Displaying 61 - 75 of 75

Sort: Relevancy | Date

News Industry News

Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases

February 26, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Conference News ISC 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

Todd Neale

February 11, 2019

Presentation BIT 2019

Stenting for Bifurcated Coronary Lesions

Presenter: Shiegru Saito

February 08, 2019

Presentation BIT 2019

Carotid Artery Stenting: Current Randomized Trial Evidence

Presenter: Jon C. George

February 08, 2019

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Caitlin E. Cox

February 07, 2019

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Caitlin E. Cox

January 31, 2019

Presentation ISET 2019

Carotid Artery Disease: Where Does Stenting Fit in 2019?

Presenter: Chris Metzger

January 30, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Shelley Wood

January 01, 2019

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

Partner Content

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

May 17, 2019

Advertisement

Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

Stenting for Bifurcated Coronary Lesions

Carotid Artery Stenting: Current Randomized Trial Evidence

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Carotid Artery Disease: Where Does Stenting Fit in 2019?

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content